The Department of Pharmaceuticals (DoP) has announced the Revamped Pharmaceuticals Technology Upgradation Assistance (RPTUAS) scheme to enhance the technological capabilities of the pharmaceutical industry, aligning it with global standards. The scheme covers pharmaceutical units with a turnover of less than Rs 500 crore for the last three years, offering incentives of up to Rs 1 crore.
The Central Drugs Standard Control Organisation (CDSCO) has been conducting risk-based inspections of drug manufacturing units as part of a nationwide crackdown on spurious and substandard drugs. Several units in Baddi, Himachal Pradesh, and Punjab have been inspected, with show-cause notices issued and production stopped at some.